Showing all 3 results

Gynecological Devices Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Assisted Reproduction Technology, Endometrial Ablation, Gynecological Resection, Uterine Tissue Removal, Uterine Fibroid Embolization, Hysteroscope, Colposcope, POP Repair & Fluid Management Devices

The full report suite on the global market for gynecological devices includes assisted reproduction technology devices, endometrial ablation devices, endometrial resection devices, mechanical uterine tissue removal devices, uterine fibroid embolization devices, hysteroscopes, colposcopes, pelvic organ prolapse repair devices, fluid management equipment and hysterosalpingography (HSG) catheter devices.


Gynecological Devices Market Analysis, Size, Trends | Europe | 2020-2026 | COVID19 | MedSuite | Includes: Assisted Reproduction Technology, Endometrial Ablation, Endometrial Resection, Uterine Fibroid Embolization, Hysteroscope, Colposcope, Fluid Management, POP Repair, Mechanical Uterine Tissue Removal, Pelvic Floor Electric Stimulation, and Laser Technology Markets

In 2020, the European gynecological devices market size was valued at €157.2 million, with over 6,700 hysteroscopes sold every year. In spite of COVID19, The market size is expected to increase at a compound annual growth rate (CAGR) of 1% to reach €286 million in 2026. Throughout this medical market research, we analyzed 54 gynecology


Uterine Fibroid Embolization Device Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Segmented by: Microsphere Market & PVA Particle Market

The global uterine fibroid embolization (UFE) device market size is estimated to increase over the forecast period to reach $92 million by 2027. The majority of the global uterine fibroid embolization device market share was controlled by Merit Medical Systems and Boston Scientific. This global market research spans over 70 countries and includes microsphere procedures and PVA particle procedures.